Janux Therapeutics, Inc. (JANX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 855.14M |
| Enterprise Value | 824.95M |
| P/E Ratio | -7.79 |
| PEG Ratio | 0.22 |
| Price/Sales Ratio | 40.46 |
| Price/Book Ratio | 0.95 |
| Enterprise/Revenue | 39.06 |
| Enterprise/EBITDA | -7.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -5.3 |
| Operating Margin | -7.26 |
| Return On Assets | -0.11 |
| Return On Equity | -0.12 |
| Revenue | 10M |
| Revenue/Share | 0.34 |
| Gross Profit | 7.97M |
| EBITDA | -111.6M |
| Net Income | -113.63M |
| Diluted EPS | -1.83 |
| Total Cash | 956.39M |
| Total Cash/Share | 15.26 |
| Total Debt | 21.57M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 17.01 |
| Book Value Per Share | 15.02 |
| 52-Week Change | -37.33 |
| 52-Week High | 35.34 |
| 52-Week Low | 12.12 |
| Moving Average 50 Days | 14.41 |
| Moving Average 200 Days | 18.05 |
| Average Volume | 969,740 |
| Shares Outstanding | 60.98M |
| % Held by Institutions | 96.16 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |